Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.7 USD | -2.03% | -0.87% | -10.78% |
13/05 | US reclassification could drive fresh research funding into pot sector | RE |
07/05 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.78% | 706.11Cr | |
+31.37% | 59TCr | |
-2.60% | 36TCr | |
+20.83% | 33TCr | |
+5.69% | 29TCr | |
+14.83% | 24TCr | |
+9.93% | 21TCr | |
-6.95% | 20TCr | |
+10.77% | 17TCr | |
+0.10% | 16TCr |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- UBS Downgrades Jazz Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $135 From $170